Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Metlife ( (MET) ) just unveiled an announcement.
On October 14, 2025, MetLife, Inc. filed a Certificate of Elimination with the Delaware Secretary of State to eliminate its 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G, which had been previously redeemed or reacquired. This action returned the shares to the status of authorized but unissued preferred stock, impacting the company’s capital structure by removing the specific designation of the Series G shares.
The most recent analyst rating on (MET) stock is a Buy with a $104.00 price target. To see the full list of analyst forecasts on Metlife stock, see the MET Stock Forecast page.
Spark’s Take on MET Stock
According to Spark, TipRanks’ AI Analyst, MET is a Outperform.
MetLife’s overall stock score reflects a stable financial performance with efficient cash flow management and a positive technical outlook. The strong earnings call sentiment and strategic initiatives further bolster confidence in the company’s future prospects. However, the decline in revenue growth and reliance on debt financing are notable risks. The valuation suggests the stock is fairly priced, providing a balanced risk-reward profile.
To see Spark’s full report on MET stock, click here.
More about Metlife
MetLife, Inc. operates in the insurance industry, providing a range of insurance products and services, including life, health, and accident insurance, as well as retirement and savings products. The company focuses on delivering financial security and protection to individuals and businesses globally.
Average Trading Volume: 3,307,049
Technical Sentiment Signal: Strong Buy
Current Market Cap: $53.05B
See more insights into MET stock on TipRanks’ Stock Analysis page.